80% decrease in cervical precursor attributed to HPV vaccine

Young women in the US today are much less likely to have cervical precursor cells than women who grew up before presenting a HPV vaccine, has shown a report from centers for disease control and prevention.

Infections with this common virus can cause cell changes that can eventually lead to cervical cancer. In fact, almost all cases of potentially deadly disease can be traced to HPV.

SH.BA has recommended anti -virus shots to predict girls since 2006 to prevent cervical cancer – and this advice seems to be being repaid. CDC researchers found a decrease of about 80% in cases of precancerous cells among women aged 20 to 24, who had cervical appearance between 2008 and 2022.

The research did not compare the vaccination status to the results of the cervical examination, so it cannot prove a causal connection. But the fact that these women were among those who were likely to have taken the shooting supports the role of the vaccine in results, according to the research team.

“These data are in accordance with the significant impact of HPV vaccination on the prevention of cervical precursors among women in the age group they are most likely vaccinated,” the report authors write.

Cancer researchers who were not included in the study also evaluated the results, with Jane Montelalle of the MD Anderson Cancer Center in Houston attributing the decline in precancerous cells in increasing the use of HPV shooting.

“This should assure parents that they are doing the right thing to vaccinate their children against HPV,” she told the Associated Press.

What is HPV?

Human papillomavirus (HPV) is a past virus through sexual activity affecting the skin. Extremely is extremely common, with a study estimating 40% of American adults aged 18 to 59 had a HPV form in 2018.

There are over 100 different types of HPV, many of which cause zero symptoms and eventually cleaned on their own. Because of this, many adults will not even understand that they have had an HPV infection.

But some types of HPV cause health problems from genital warts in certain cancers in both women and men. Almost all cases (99%) of cervical cancer are thought to have been caused by infection with one of these “high -risk” HPV strains. The vast majority of women who experience HPV -related changes in their cervical cells, however, never continue to develop the disease.

What is the HPV vaccine?

Sold from Merck & Co. Under the name “Gardasil”, HPV vaccines Train the body’s immune system to better recognize and attack some “high risk” strains of the virus. Clinical studies show that it is safe and effective, with most people experiencing soft side effects, if any.

SH.BA recommends shooting for all children aged 11 or 12 years. Capture doses are advised for anyone up to 26 years old, who lost one of their shooting.

Does the HPV vaccine work?

Since it was first approved in the mid -2000s, the Shave scientist was studying the influence on the real world of the HPV vaccine. Countries with cervical examination programs associated with age like the UK have demonstrated mass points in cases of precancerous cells and cervical cancer itself.

In 2023, researchers in England found a “dramatic decrease” in high -risk HPV infections in young women who were likely to have been vaccinated against the virus. An early study estimated that it had prevented about 500 cases of cervical cancer in the country until 2019 and “almost eliminated” disease among born women since 1995.

The HPV vaccine is an essential pronig in the world health organization to eliminate cervical cancer globally within the next century. Some places that are already giving vaccinations and scale shows think they will seal the disease even faster, with England aiming to “eradicate” it by 2040.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top